VENTURE LIFE GROUP PLC Logo

VENTURE LIFE GROUP PLC

Develops, manufactures, and distributes consumer self-care products and medical devices globally.

VLG | IL

Overview

Corporate Details

ISIN(s):
GB00BFPM8908 (+2 more)
LEI:
213800S8CZUPLAB2KC70
Country:
United Kingdom
Address:
12 THE COURTYARD, RG12 2XB BRACKNELL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Venture Life Group PLC is an international consumer self-care company that develops, manufactures, and distributes products for the global market. The company's portfolio focuses on non-prescription items, including medical devices and food supplements, designed to meet the growing demand for preventative wellness and self-medication. It operates an extensive distribution network with over 200 partners in more than 90 countries. Key brands in its portfolio include Earol® and EarolSwim®, which provide clinically proven ENT care solutions. Venture Life's business model is centered on commercializing products that address the needs of an aging population and respond to pressures on global healthcare budgets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 17:40
Director's Dealing
Director/PDMR Shareholding
English 22.3 KB
2025-09-30 08:01
Transaction in Own Shares
Share Buyback Programme
English 14.1 KB
2025-09-29 13:19
Report Publication Announcement
Investor Presentation via Investor Meet Company
English 9.6 KB
2025-09-24 15:38
Report Publication Announcement
Change of Accounting Reference Date
English 10.4 KB
2025-09-08 08:00
Board/Management Information
Directorate Change
English 11.5 KB
2025-08-19 15:04
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-08-05 16:43
Post-Annual General Meeting Information
Result of General Meeting
English 10.1 KB
2025-07-07 17:21
Director's Dealing
Director/PDMR Shareholding
English 22.1 KB
2025-07-03 08:00
Director's Dealing
Director Dealings
English 55.5 KB
2025-07-02 08:00
Pre-Annual General Meeting Information
Notice of General Meeting & Investor Presentation
English 11.8 KB
2025-07-01 17:08
Major Shareholding Notification
Holding(s) in Company
English 53.0 KB
2025-06-30 16:13
Earnings Release
Final Results for year ended 31 December 2024
English 559.9 KB
2025-05-19 08:01
Remuneration Information
Director Dealings
English 10.5 KB
2025-05-12 09:49
M&A Activity
Replacement: Cash sale of CDMO operations
English 27.4 KB
2025-02-20 14:14
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB

Automate Your Workflow. Get a real-time feed of all VENTURE LIFE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VENTURE LIFE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896

Talk to a Data Expert

Have a question? We'll get back to you promptly.